Mildred Scheel Lectureship

Outstanding international cancer researchers provide insights into current challenges in oncology.

Click here for German version

The Mildred Scheel Lectureship, funded by German Cancer Aid and the inviting Comprehensive Cancer Centers, honors outstanding cancer researchers. Exciting discussions with these pioneers can substantially encourage young researchers to pursue a scientific career.

This unique lectureship pays tribute to the remarkable engagement of Dr. Mildred Scheel in the fight against cancer. During her lifetime and still today she is nationally and internationally highly regarded by cancer researchers and the general public.

The Mildred Scheel Lectureship was established jointly by German Cancer Aid, the German Cancer Research Center (DKFZ), the National Center for Tumor Diseases Heidelberg and the DKFZ Executive Women’s Initiative in 2012. Since then it has been extended to all Comprehensive Cancer Centers in Germany that are connected in the ‘Network Oncology Centers of Excellence’.

Contact information

Dr. Alexia Arnold
Mildred Scheel Lectureship Coordination
National Center for Tumor Diseases (NCT) Heidelberg
Division of Preventive Oncology
Im Neuenheimer Feld 460
69120 Heidelberg, Germany
Phone: +49 (0) 6221/56 357 83
E-Mail: Alexia.Arnold@nct-heidelberg.de

Past Lectures

Prof. Dr. Margaret A. Shipp
Dana-Farber Cancer Institute, Boston, Massachusetts
Title: Targetable Genetic Signatures in Lymphoid Malignancies
(2018 in Cologne, Mainz und Würzburg)

Prof. Dr. Ruth Pfeiffer

National Cancer Institute, Bethesda, MD
Title: Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening
(2018 in Heidelberg and Munich)

Prof. Dr. Eileen White
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
Title: Autophagy and cancer metabolism
(2017 in Frankfurt/Main)

Prof. Dr. Mina J. Bissell
Lawrence Berkeley National Laboratory, CA
Title: Why don’t we get more cancer: The critical role of extracellular matrix and tissue architecture in gene expression and function in both normal and malignant breast?
(2017 in Essen and Cologne)

Prof. Dr. Anne-Lise Børresen-Dale
K.G. Jebsen Center for Breast Cancer Research, Oslo
Title: Challenges in translating „omics“ for personalized treatment of breast cancer
(2015 in Dresden, Berlin, Heidelberg and Cologne)

Prof. Dr. Connie Eaves
BC Cancer Agency
Title: Heterogeneity of Adult Tissue Stem Cell Behavior
(2014 in Heidelberg, Cologne and Hamburg)

Dr. Margaret Foti

American Association for Cancer Research
Title: AACR and its Leadership Role in the Conquest of Cancer
(2013 in Heidelberg)

Prof. Dr. Janet Rowley †
University of Chicago
Title: The Philadelphia Chromosome Story
(2012 in Heidelberg)

Prof. Dr. Lisa Coussens
Oregon Health Sciences University
Title: Inflammation, Tumor Microenvironment and Cancer
(2012 in Heidelberg)

Gemeinsam können wir viel erreichen!